跳至主要内容
临床试验/ACTRN12611000068965
ACTRN12611000068965进行中(未招募)2 期

Randomised controlled trial to determine whether once-daily insulin detemir slows decline in weight and lung function in patients with cystic fibrosis and early insulin deficiency

Sydney Children's Hospital0 个研究点目标入组 95 人开始时间: 2011年1月19日最近更新:
适应症

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
95

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
5 Years 至 19 Years(—)
性别
All

入选标准

  • (1) Patients with Cystic Fibrosis aged >5 yrs attending Sydney Children’s Hospital (SCH), Children’s Hospital Westmead (CHW), John Hunter Children’s Hospital (JHCH), Lady Cilento Children's Hospital Brisbane (LCCB), or Women's and Children's Hospital Adelaide (WCHA).
  • (2) Cystic Fibrosis Insulin Deficiency Stage 1 or 2 (defined as peak blood glucose >=8.2 and 120-minute blood glucose <11.1mmol/l on OGTT performed within the last 6 months, when respiratory function stable, as judged by the treating respiratory team.

排除标准

  • (1) Diabetes, defined as 120-minute blood glucose on OGTT >=11.1mmol/L or fasting blood glucose >= 7mmol/L. Such patients will be offered insulin treatment as standard clinical care.
  • (2) Unstable respiratory disease (hospital admission for treatment of respiratory exacerbation within the last month)
  • (3) Current treatment with systemic glucocorticoids or treatment with systemic glucocorticoids of more than 1 month duration, within the last 12 months.
  • (4) Current treatment with fluoroquinolone antibiotics.

研究者

发起方
Sydney Children's Hospital

相似试验

CF-IDEA (Cystic Fibrosis - Insulin Deficiency, Early... | 临床试验